Tazarotene - AlmirallAlternative Names: LAS41006
Latest Information Update: 05 Aug 2015
Price : *
At a glance
- Originator Almirall S.A.
- Class Antiacnes; Antipsoriatics; Keratolytics; Nicotinic-acids; Retinoids; Small molecules
- Mechanism of Action Retinoic acid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Psoriasis
Most Recent Events
- 07 May 2015 Almirall completes a phase II trial in Psoriasis in Germany (NCT02235480)